Herpes simplex virus infection in pregnancy: Diagnosis and significance

Intervirology

Volumn 41, Issue 4-5, 1998, Pages 185-190

  Desselberger, Ulrich ^a  

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

Epidemiology, HSV; Herpes simplex virus; Infection in pregnancy, HSV; Latency, HSV; Neonatal infection, HSV; Pathogenesis, HSV

Indexed keywords

ACICLOVIR; ANTIVIRUS AGENT; FAMCICLOVIR; VALACICLOVIR;

CLINICAL FEATURE; FEMALE; GENITAL TRACT INFECTION; HERPES SIMPLEX; HUMAN; IMMUNE RESPONSE; NEWBORN INFECTION; ORAL DRUG ADMINISTRATION; PATHOGENESIS; POLYMERASE CHAIN REACTION; PREGNANCY; PRIORITY JOURNAL; REVIEW; TOPICAL DRUG ADMINISTRATION; VIRUS CULTURE; VIRUS MORPHOLOGY; VIRUS REPLICATION;

DISEASE TRANSMISSION, VERTICAL; FEMALE; HERPES GENITALIS; HERPES SIMPLEX; HERPESVIRUS 1, HUMAN; HERPESVIRUS 2, HUMAN; HUMANS; INFANT, NEWBORN; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS;

DNA VIRUSES; HERPES; SIMPLEXVIRUS;

EID: 0032448205     PISSN: 03005526     EISSN: None     Source Type: Journal    
DOI: 10.1159/000024934     Document Type: Review

References (30)

1. Schrag JD, Prasad BVV, Rixon FJ, Chiu W: Three dimensional structure of the HSV-1 nucleocapsid. Cell 1989;56:651-660.
2. Roizman, B, Sears AE: Herpes simplex viruses and their replication; in Fields BN, Knipe DM, Howley PM, et al (eds): Fields Virology, ed 3. Philadelphia, Lippincott Raven, 1996, pp 2231-2295.
3. Knipe DM: The replication of herpes simplex virus; in Stanberry LR (ed): Genital and Neonatal Herpes. Chichester, Wiley, 1996, pp 1-29.
4. McGeoch DJ, Dalrymple MA, Davison AJ, Dolan A, Frame MC, McNab D, Perry LJ, Scott JE, Taylor P: The complete DNA sequence of the long unique region in the genome of herpes simplex virus type 1. J Gen Virol 1988;69:1531-1574.
5. Wagner EK, Bloom DC: Experimental investigation of herpes simplex virus latency. Clin Microbiol Rev 1997;10:419-443.
6. Whitley RJ: Herpes simplex viruses; in Fields BN, Knipe DM, Howley PM, et al (eds): Fields Virology, ed 3. Philadelphia, Lippincott Raven, 1996, pp 2297-2342.
7. Stanberry LR: The pathogenesis of herpes simplex virus infections; in Stanberry LR (ed): Genital and Neonatal Herpes. Chichester, Wiley, 1996, pp 31-47.
8. Pass RF, Whitley RJ, Whelchel JD, Diethelm AG, Reynolds DW, Alford CA: Identification of patients with increased risk of infection with herpes simplex virus after renal transplantation. J Infect Dis 1979;140:487-492.
9. Sullender WM, Yasukawa LL, Schwartz M, Pereira L, Hensleigh PA, Prober CG, Arvin AM: Type-specific antibodies to herpes simplex virus type 2 (HSV-2) glycoprotein G in pregnant women, infants exposed to maternal HSV-2 infection at delivery, and infants with neonatal herpes. J Infect Dis 1988;157:164-171.
10. Nahmias AJ, Lee FK, Keyserling HL: The epidemiology of genital herpes; in Stanberry LR (ed): Genital and Neonatal Herpes. Chichester, Wiley, 1996, pp 93-108.
11. Ashley R, Corey L: Herpes simplex viruses and B virus; in Schmidt NJ, Emmons R (eds): Diagnostic Procedures for Viral, Rickettsial and Chlamydial Infections, ed 6. Washington, American Public Health Association, 1989, pp 265-317.
12. Cone RW, Swenson PD, Hobson AC, Remington M, Corey L: Herpes simplex virus detection from genital lesions: A comparative study using antigen detection (Herp Check) and culture. J Clin Microbiol 1993;31:1774-1776.
13. Lakeman FD, Whitley RJ: Diagnosis of herpes simplex encephalitis; application of the polymerase chain reaction to cerebrospinal fluid from brain-biopsied patients and correlation with disease. J Infect Dis 1995;171:857-863.
14. Cone RW, Hobson AC, Brown Z, et al: Frequent detection of genital herpes simplex virus DNA by polymerase chain reaction among pregnant women. JAMA 1994;272:792-796.
15. Ashley R, Cent R, Maggs V, et al: Inability of enzyme immunoassays to accurately discriminate between infections with herpes simplex virus types 1 and 2. J Infect Dis 1991;115:520-526.
16. Safrin S, Arvin A, Mills J, Ashley R: Comparison of the Western immunoblot assay and a glycoprotein G enzyme immunoassay for detection of serum antibodies to herpes simplex virus type 2 in patients with AIDS. J Clin Microbiol 1992;30:1312-1314.
17. Frenkel LM, Garratty EM, Shen JP, et al: Clinical reactivation of herpes simplex virus type 2 infection in seropositive pregnant women with no history of genital herpes. Ann Intern Med 1993;118:414-418.
18. Arvin AM: The epidemiology of perinatal herpes simplex virus infection; in Stanberry LR (ed): Genital and Neonatal Herpes. Chichester, Wiley, 1996, pp 179-192.
19. Hutto C, Arvin AM, Jacobs R, et al: Intrauterine herpes simplex virus infections. J Pediatr 1987;110:97-101.
20. Prober CG, Hensleigh PA, Boucher FD, Yasukawa LL, Au DS, Arvin AM: Use of viral cultures at delivery to identify neonates exposed to herpes simplex virus. N Engl J Med 1988; 318:887-891.
21. Brown Z, Benedetti J, Ashley R, et al: Neonatal herpes simplex virus infection in relation to asymptomatic maternal infection at the time of labor. N Engl J Med 1991;324:1247-1252.
22. Brown ZA, Selke S, Zeh J, Kopelman J, Maslow A, Ashley R, Watts DH, Berry S, Herd M, Corey L: The acquisition of herpes simplex virus during pregnancy. N Engl J Med 1997; 337:509-515.
23. Arvin AM, Prober CG: Herpes simplex virus type 2 - A persistent problem (editorial). N Engl J Med 1997;337:1158-1159.
24. Eglund JA, Fletcher CV, Balfour HH Jr: Acyclovir therapy in neonates. J Pediatr 1991;119: 129-135.
25. Kimberlin DW, Kimberlin DF, Whitley RJ: The treatment, management and prevention of neonatal herpes simplex virus infections; in Stanberry LR (ed): Genital and Neonatal Herpes. Chichester, Wiley, 1996, pp 209-236.
26. Bravo FJ, Mani CM, Bourne N, et al: Effect of antibody or acyclovir on HIV-2 infection in newborn guinea pigs. Pediatr Res 1992;31: 274A.
27. Frenkel LM, Brown ZA, Bryson YJ, et al: Pharmakokinetics of acyclovir in the term human pregnancy and neonate. Am J Obstet Gynecol 1991;164:569-576.
28. Stray-Pedersen B: Acyclovir in late pregnancy to prevent neonatal herpes simplex. Lancet 1990;336:756.
29. Straus SE, Savarese B, Tigges M, et al: Induction and enhancement of immune responses to herpes simplex virus type 2 in humans by use of a recombinant glycoprotein D vaccine. J Infect Dis 1993;167:1045-1052.
30. Wald A, Benedetti J, Davis G, et al: A randomised double-blind, comparative trial comparing high- and standard-dose oral acyclovir for first episode genital herpes infections. Antimicrob Agents Chemother 1994;38:174-176.